Gilead Sciences (Foster City, CA) Completes Acquisition Of Corus Pharma, Inc.
Published: Aug 14, 2006
Gilead Sciences, Inc. (Nasdaq:GILD) announced today that it has completed its acquisition of Corus Pharma. Gilead also announced that the company has received regulatory clearance by the United States Federal Trade Commission under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. Gilead will provide updated full year 2006 expense guidance reflecting the impact of the Corus acquisition on the company's third quarter 2006 earnings conference call on October 18, 2006.